The use of first generation versus second generation antipsychotics as add-on or as switch treatment and its effect on QTc interval: The Italian experience in a real-world setting

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 1, 2011, Pages 225-230

  Di Sciascio, Guido ^a   Calo S ^a   Amodio, G ^a   D'Onofrio, S ^b   Pollice, R ^b  

^a UNIVERSITY OF BARI   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Atypical antipsychotics; Bipolar disorder; ECG; Schizophrenia; Typical antipsychotics

Indexed keywords

AMITRIPTYLINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLOTIAPINE; CLOZAPINE; ESCITALOPRAM; FLUPHENAZINE DECANOATE; FLUVOXAMINE; HALOPERIDOL; HALOPERIDOL DECANOATE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; SULPIRIDE; VALPROIC ACID; VENLAFAXINE; AMISULPRIDE; ARIPIPRAZOLE; CARBOLITHIUM; FIRST GENERATION ANTIPSYCHOTIC AGENT; LITHIUM; PERPHENAZINE; SECOND GENERATION ANTIPSYCHOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; ELECTROCARDIOGRAM; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; SCHIZOPHRENIA; ADD ON THERAPY; AGED; ECG ABNORMALITY; HOSPITALIZATION; ITALY; LABORATORY TEST; MENTAL DISEASE; OBSERVATIONAL STUDY; QTC INTERVAL; SAMPLE SIZE; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; MIDDLE AGED;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 79957804999     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400127     Document Type: Article

References (15)

1. Colton CW, Manderscheid RW. Free in PMC Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006; 3:A42.
2. Glassman AH. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J Clin Psychiatry 2005; 66(S):5-10.
3. Zareba W. Drug induced QT prolongation. Cardiol J 2007; 14:523-33. (Pubitemid 351278615)
4. Yap YG, Camm AJ. Drug-induced QT prolongation and torsades de pointes. Heart 2003; 89:1363-72.
5. Straus SM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164:1293-7.
6. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. Thioridazine and sudden unexplained death in psychiatric inpatients. Br J Psychiatry 2002; 180:515-22. (Pubitemid 34596802)
7. Vieweg WVR. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs. J Clin Psychiatry 2002; 63:18-24.
8. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360:225-35.
9. Correll CU, Frederickson AM, Figen V, Ginn-Scott EJ, Pantaleon Moya RA, Kane JM, Manu P. The QTc interval and its dispersion in patients receiving two atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci 2009; 259:23-7.
10. Diagnostic and statistical manual of mental disorders (4th edition), American Psychiatric Association, 1994, Washington DC.
11. E14 clinical evaluation of QT/QTc interval prolongation and proarhythmic potential for non-antiarhythmic drugs. US Department of Health and Human Services Food and Drug Administration. International Conference on Harmonisation; 2005. http://www.fda.gov.cber.gdlns/iche14qtc.htm.
12. Rey MJ, Schulz P, Costa C, et al. Guidelines for the dosage of neuroleptics I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychol 1989; 4:95-104.
13. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64:663-7. (Pubitemid 36750143)
14. Van Noord C, Straus SM, Sturkenboom MC, et al. Psychotropic Drugs Associated With Corrected QT Interval Prolongation. J Clin Psychopharmacol 2009; 29:9-15.
15. Ramos-Ríos R, Arrojo-Romero M, Paz-Silva E, et al. QTc interval in a sample of long-term schizophrenia inpatients. Schizophrenia Research 2010; 116:35-43.